Baron Silver Stevens Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$543K Sell
22,560
-300
-1% -$7.85K 0.07% 89
2026
Q1
$642K Hold
22,860
0.09% 75
2025
Q4
$569K Sell
22,860
-1,127
-5% -$28.4K 0.08% 79
2025
Q3
$611K Buy
23,987
+14,173
+144% +$350K 0.09% 76
2025
Q2
$238K Buy
9,814
+343
+4% +$8K 0.04% 125
2025
Q1
$240K Buy
9,471
+32
+0.3% +$837 0.04% 108
2024
Q4
$250K Sell
9,439
-62
-0.7% -$1.68K 0.04% 104
2024
Q3
$275K Sell
9,501
-423
-4% -$12.3K 0.05% 98
2024
Q2
$278K Sell
9,924
-2,348
-19% -$64.6K 0.05% 93
2024
Q1
$341K Buy
12,272
+477
+4% +$13.2K 0.07% 85
2023
Q4
$340K Sell
11,795
-3,337
-22% -$101K 0.07% 76
2023
Q3
$502K Buy
15,132
+738
+5% +$26.1K 0.11% 60
2023
Q2
$528K Buy
14,394
+180
+1% +$7.01K 0.12% 59
2023
Q1
$580K Sell
14,214
-286
-2% -$12.4K 0.15% 53
2022
Q4
$743K Sell
14,500
-204
-1% -$9.78K 0.18% 44
2022
Q3
$173K Sell
14,704
-2,009
-12% -$97.6K 0.05% 89
2022
Q2
$876K Buy
16,713
+1,923
+13% +$98K 0.23% 40
2022
Q1
$765K Buy
14,790
+2,189
+17% +$114K 0.18% 45
2021
Q4
$744K Buy
12,601
+895
+8% +$44.3K 0.18% 39
2021
Q3
$503K Sell
11,706
-619
-5% -$27.4K 0.13% 44
2021
Q2
$482K Buy
12,325
+824
+7% +$32K 0.13% 48
2021
Q1
$416K Buy
11,501
+1,000
+10% +$35.5K 0.23% 28
2020
Q4
$386K Buy
+10,501
New +$385K 0.13% 45

Other funds holding PFE

Baron Silver Stevens Financial Advisors's PFE Position: Q2 2026 in Review

Baron Silver Stevens Financial Advisors reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $7.85K and leaving 22,560 shares worth $543K. The position accounts for 0.07% of the portfolio, ranked #89.

Baron Silver Stevens Financial Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $876K in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Baron Silver Stevens Financial Advisors held 22,560 shares of Pfizer worth $543K as of Q2 2026.
  • Baron Silver Stevens Financial Advisors sold 300 Pfizer shares in Q2 2026, an estimated $7.85K.
  • Pfizer made up 0.07% of Baron Silver Stevens Financial Advisors's portfolio in Q2 2026, its #89 holding.
  • Baron Silver Stevens Financial Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Baron Silver Stevens Financial Advisors's Pfizer position peaked at $876K in Q2 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.